Boult Wade Tennant
People » Thomas Davis

Thomas Davis

Patent Attorney

London

Contact
v-card Download V-card
Address
Memberships
  • CIPA
  • EPI
  • AIPPI
Qualifications
  • European Patent Attorney
  • Chartered Patent Attorney
  • Certificate in Intellectual Property Law, Queen Mary University of London
  • MRes Molecular and Cellular Biosciences, Imperial College London
  • BSc (Hons) Biochemistry, Imperial College London

Prior to joining Boult, I completed a BSc in Biochemistry and a Master of Research (MRes) in Molecular and Cellular Biosciences at Imperial College London.

My practical experience includes a variety of biochemical, biophysical, molecular and cell biology techniques, with my postgraduate research having investigated the structure and function of protein complexes involved in neurological disorders.

In my current role, I assist with the drafting, filing and prosecution of patent applications in the UK, Europe and worldwide. I have particular experience prosecuting large, multi-country patent families, with a focus on antibodies, small molecule therapeutics and diagnostics. I also enjoy assisting with contentious matters such as opposition proceedings before the European Patent Office.

Recent experience

Assisting with the filing, prosecution and management of a large pharmaceutical patent portfolio in multiple countries.

Assisting with the drafting of a patent application for a client’s new probiotic therapy.

Assisting with preparations for EPO opposition proceedings for a client’s cell-based immunotherapy patent.

Publications
Relevant Search Terms
Recommended Sites
  • Susi Fish - Linkedin
  • Jonathan Pratt – CIPA council
  • IP Kat
Suggested Media
  • Professionals in the Pharmaceutical and Biotech Industry on LinkedIn
  • Royal Pharmaceutical Society
  • British Pharmacological Society
  • British Crystallographic Association
Recognitions
Additional Info
Languages
“In my current role, I assist with the drafting, filing and prosecution of patent applications in the UK, Europe and worldwide. I have particular experience prosecuting large, multi-country patent families, with a focus on antibodies, small molecule therapeutics and diagnostics.”
Sector Experience
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Recombinant protein production and purification
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
Electronics and Electrical Devices
  • Medical devices
Medical Devices and Diagnostics
  • Devices
  • Drug delivery
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Drug delivery
  • Small molecule pharmaceuticals

Prior to joining Boult, I completed a BSc in Biochemistry and a Master of Research (MRes) in Molecular and Cellular Biosciences at Imperial College London.

My practical experience includes a variety of biochemical, biophysical, molecular and cell biology techniques, with my postgraduate research having investigated the structure and function of protein complexes involved in neurological disorders.

In my current role, I assist with the drafting, filing and prosecution of patent applications in the UK, Europe and worldwide. I have particular experience prosecuting large, multi-country patent families, with a focus on antibodies, small molecule therapeutics and diagnostics. I also enjoy assisting with contentious matters such as opposition proceedings before the European Patent Office.

Recent experience

Assisting with the filing, prosecution and management of a large pharmaceutical patent portfolio in multiple countries.

Assisting with the drafting of a patent application for a client’s new probiotic therapy.

Assisting with preparations for EPO opposition proceedings for a client’s cell-based immunotherapy patent.

Publications
Relevant Search Terms
Recommended Sites
  • Susi Fish - Linkedin
  • Jonathan Pratt – CIPA council
  • IP Kat
Suggested Media
  • Professionals in the Pharmaceutical and Biotech Industry on LinkedIn
  • Royal Pharmaceutical Society
  • British Pharmacological Society
  • British Crystallographic Association
Recognitions
Additional Info

Insights

image
IP updates
G2/21.

The Enlarged Board of Appeal of the European Patent Office issued the decision in referral G2/21 on 23 March 2023. This referral concerned the admissibility of post-published evidence in the assessment of inventive step.

image
IP updates
Plausibility and Post-Published Evidence (G2/21).

The Enlarged Board of Appeal of the European Patent Office has been challenged with a new referral (G2/21) concerning the admissibility of

image
IP updates
EPO Guidelines for Examination: Patentability of antibodies

The latest changes to the EPO Guidelines for Examination provide several updates to (i) the patent protection of antibodies, and (ii) the interpretation

image
IP updates
Updates to the EPO Guidelines for Examination: Patentability of plants and animals, human-derived cells, and methods of treatment by therapy

The latest changes to the EPO Guidelines for Examination provide several updates in relation to the patent protection of (i) plants and

INSIGHTS